CompletedNot Applicable

End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)

United States30 participantsStarted 2006-09

Plain-language summary

The purpose of this research study is to see how effective bioelectric impedance analysis (BIA) is in determining body composition (the amount of fat versus muscle in the body) and nutritional status in patients with End Stage Liver Disease (ESLD)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with ESLD requiring LVP. * Age over 18. * Ability to provide written informed consent. Exclusion Criteria: * Organ retransplant candidates. * Patient with use of any investigational agent within 30 days before LVP. * Pregnant or lactating. * Patients with non-bioprosthetic heart valves pacemakers, defibrillators, artificial joints, pins, plates, or other types of metal objects in the body. * Amputations other than fingers or toes.

What they're measuring

Efficacy and utility of BIA in determining body composition and nutritional status using multi-frequency machines in patients with ESLD and ascites requiring LVP.

Timeframe: Before and after large volume paracentesis

Trial details

NCT IDNCT00374582

SponsorUniversity of Cincinnati

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-05

View on ClinicalTrials.gov More End Stage Liver Disease trials